195 related articles for article (PubMed ID: 10868638)
1. Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial.
Neuhaus P; Klupp J; Langrehr JM; Neumann U; Gebhardt A; Pratschke J; Tullius SG; Lohmann R; Radke C; Rayes N; Neuhaus R; Bechstein WO
Transplantation; 2000 Jun; 69(11):2343-53. PubMed ID: 10868638
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation.
Langrehr JM; Klupp J; Pfitzmann R; Neumann U; Lohmann R; Jonas S; Neuhaus R; Steinmüller T; Neuhaus P
Transplant Proc; 2001; 33(1-2):1520. PubMed ID: 11267404
[No Abstract] [Full Text] [Related]
3. Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial.
Langrehr JM; Klupp J; Junge G; Jonas S; Neuhaus R; Bechstein WO; Neuhaus P
Transplant Proc; 2001 May; 33(3):2330-1. PubMed ID: 11377549
[No Abstract] [Full Text] [Related]
4. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
[TBL] [Abstract][Full Text] [Related]
6. Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation.
Klupp J; Bechstein WO; Pratschke J; Tullius SG; Gebhard A; Lobeck H; Langrehr JM; Neuhaus R; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1443-4. PubMed ID: 9636585
[No Abstract] [Full Text] [Related]
7. Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation.
Lladó L; Figueras J; Ramos E; Lama C; Busquets J; Ibáñez L; Rafecas A; Fabregat J; Torras J; Jaurrieta E
Transplant Proc; 2002 Feb; 34(1):108. PubMed ID: 11959210
[No Abstract] [Full Text] [Related]
8. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.
Eason JD; Nair S; Cohen AJ; Blazek JL; Loss GE
Transplantation; 2003 Apr; 75(8):1396-9. PubMed ID: 12717237
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation.
Langrehr JM; Nüssler NC; Neumann U; Guckelberger O; Lohmann R; Radtke A; Jonas S; Klupp J; Steinmüller T; Lobeck H; Meuer S; Schlag H; Lemmens HP; Knoop M; Keck H; Bechstein WO; Neuhaus P
Transplantation; 1997 Jun; 63(12):1772-81. PubMed ID: 9210503
[TBL] [Abstract][Full Text] [Related]
10. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
[No Abstract] [Full Text] [Related]
11. Steroid-free immunosuppression during and after liver transplantation--a 3-yr follow-up report.
Pirenne J; Aerts R; Koshiba T; Van Gelder F; Roskams T; Schetz M; Verhaegen M; Lauwers P; Fevery J; Nevens F
Clin Transplant; 2003 Jun; 17(3):177-82. PubMed ID: 12780665
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
[TBL] [Abstract][Full Text] [Related]
13. [Dual, triple, and quadruple oral tacrolimus-based immunosuppression regimens after orthotopic liver transplantation: a randomised comparative study of regimens].
Lu AW; Zheng SS; Wu J; Liang TB; Wang WL; Shen Y; Zhang M; Shi SH; Wu YS
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3389-92. PubMed ID: 17313848
[TBL] [Abstract][Full Text] [Related]
14. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
15. Antilymphocyte globulins versus OKT3 as prophylactic treatment in highly sensitized renal transplant recipients.
Vela C; Cristol JP; Chong G; Okamba A; Lorho R; Mion C; Mourad G
Transpl Int; 1994; 7 Suppl 1():S259-62. PubMed ID: 11271219
[TBL] [Abstract][Full Text] [Related]
16. FK506 for primary and rescue therapy following liver transplantation.
Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
[No Abstract] [Full Text] [Related]
17. Simultaneous kidney-pancreas transplantation without antilymphocyte induction.
Reddy KS; Stratta RJ; Shokouh-Amiri H; Alloway R; Somerville T; Egidi MF; Gaber LW; Gaber AO
Transplantation; 2000 Jan; 69(1):49-54. PubMed ID: 10653379
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
[TBL] [Abstract][Full Text] [Related]
19. Low rejection rates with tacrolimus-based dual and triple regimens following liver transplantation.
Boillot O; Baulieux J; Wolf P; Messner M; Cherqui D; Gugenheim J; Pageaux G; Belghiti J; Calmus Y; Le Treut Y; Neau-Cransac M; Samuel D
Clin Transplant; 2001 Jun; 15(3):159-66. PubMed ID: 11389705
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
Langrehr JM; Glanemann M; Guckelberger O; Klupp J; Neumann U; Machens C; Lohmann R; Knoop M; Lobeck H; Schlag H; Keck H; Settmacher U; Bechstein WO; Neuhaus PJ
Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
